<DOC>
	<DOCNO>NCT00231426</DOCNO>
	<brief_summary>The ASSURE Study evaluate shock conversion performance program first shock implantable cardioverter-defibrillation ( ICD ) base implant test consist either 1 ) single induction ventricular fibrillation ( VF ) subsequent demonstration conversion success 14 J 2 ) upper limit vulnerability ( ULV ) test 14 J .</brief_summary>
	<brief_title>ASSURE Study - Arrhythmia Single Shock DFT Versus ULV : Risk Reduction Evaluation With ICD Implantations</brief_title>
	<detailed_description />
	<mesh_term>Tachycardia</mesh_term>
	<criteria>Patients meet current indication ICD include cardiac resynchronization therapy ( CRT ) device Patients sign date Patient Informed Consent form prior implant visit Patients remain clinical care enrol physician approved center Patients receive leftsided pectoral implantation ICD lead place right ventricular apex Patients minimum R wave least 7 mV ; ICD replacement , patient minimum chronic R wave least 5 mV Patients involve NonInvasive Programming Stimulation ( NIPS ) study Patients undergo lead repositioning Patients expect receive heart transplant duration study Patients likely receive tricuspid valve prosthesis Patients currently enrol another investigational study registry would directly impact treatment outcome current study Patients young 18 year age Patients pregnant plan become pregnant study Patients whose life expectancy le 12 month Patients mentally incompetent sign Patient Informed Consent form comply study</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2006</verification_date>
</DOC>